Smith’s Food & Drug Stores has donated $2 million to children’s hospitals in the Intermountain West as part of its annual campaign to support charity healthcare programs for injured and sick children who are less fortunate.
University of New Mexico Children’s Hospital received $350,000 of the donation, bringing Smith’s total contribution to the facility at $955,000 since 2011. Other hospitals receiving donations in major Smith’s markets include: Primary Children’s Hospital in Salt Lake City; St. Rose Dominican Hospital in Las Vegas; and Renown Children's Hospital in Reno.
Smith’s is committed to further the mission of each hospital in caring for children battling cancer, heart disease, cystic fibrosis, diabetes, prematurity, and many other illnesses and injuries. The contribution is a result of fundraising efforts over the summer with customers, Smith’s associates, annual vendor golf tournament and change collected from coin boxes at check out stands.
The UNMCH is New Mexico's only dedicated Children's Hospital trained to deliver the most advanced neonatology and pediatric care. Nearly 60,000 children receive services each year, over half of whom live outside of the Albuquerque area. The range of care extends from acute illness and trauma to chronic disease and disability.
"Smith’s Food & Drug and its customers continue to be one of our most valued supporters in furthering our mission of caring for critically ill and injured children,” said Steve McKernan, UNMCH CEO. “This incredibly generous contribution supports programs that make UNMCH one of the finest children’s hospitals in the country.”
UNM Hospital was founded more than 50 years ago and encompass a system of five state-of-the-art health care facilities: UNM Hospital, UNM Children's Hospital (the only Children's Miracle Network Hospital in the state of New Mexico), UNM Carrie Tingley Hospital, UNM Psychiatric Center, and UNM Children's Psychiatric Center. These five facilities all work together to provide the best surgical techniques, medical treatments and the latest drug therapies to the entire state of New Mexico, Southern Colorado and Eastern Arizona.